College of Pharmacy, Seoul National University, Seoul, Korea.
College of Pharmacy, Dongguk University, Goyang, Korea.
Clin Mol Hepatol. 2020 Oct;26(4):715-727. doi: 10.3350/cmh.2020.0173. Epub 2020 Sep 22.
Alcoholic and non-alcoholic liver diseases begin from an imbalance in lipid metabolism in hepatocytes as the earliest response. Both liver diseases share common disease features and stages (i.e., steatosis, hepatitis, cirrhosis, and hepatocellular carcinoma). However, the two diseases have differential pathogenesis and clinical symptoms. Studies have elucidated the molecular basis underlying similarities and differences in the pathogenesis of the diseases; the factors contributing to the progression of liver diseases include depletion of sulfhydryl pools, enhanced levels of reactive oxygen and nitrogen intermediates, increased sensitivity of hepatocytes to toxic cytokines, mitochondrial dysfunction, and insulin resistance. Endoplasmic reticulum (ER) stress, which is caused by the accumulation of misfolded proteins and calcium depletion, contributes to the pathogenesis, often causing catastrophic cell death. Several studies have demonstrated a mechanism by which ER stress triggers liver disease progression. Autophagy is an evolutionarily conserved process that regulates organelle turnover and cellular energy balance through decomposing damaged organelles including mitochondria, misfolded proteins, and lipid droplets. Autophagy dysregulation also exacerbates liver diseases. Thus, autophagy-related molecules can be potential therapeutic targets for liver diseases. Since ER stress and autophagy are closely linked to each other, an understanding of the molecules, gene clusters, and networks engaged in these processes would be of help to find new remedies for alcoholic and non-alcoholic liver diseases. In this review, we summarize the recent findings and perspectives in the context of the molecular pathogenesis of the liver diseases.
酒精性和非酒精性肝病都始于肝细胞脂质代谢失衡,这是最早的反应。两种肝病都具有共同的疾病特征和阶段(即脂肪变性、肝炎、肝硬化和肝细胞癌)。然而,这两种疾病的发病机制和临床症状不同。研究已经阐明了疾病发病机制相似和不同的分子基础;导致肝病进展的因素包括巯基池耗竭、活性氧和氮中间产物水平升高、肝细胞对毒性细胞因子的敏感性增加、线粒体功能障碍和胰岛素抵抗。内质网(ER)应激是由错误折叠蛋白的积累和钙耗竭引起的,它导致了发病机制,通常导致灾难性的细胞死亡。一些研究已经证明了 ER 应激引发肝病进展的机制。自噬是一种进化上保守的过程,通过分解包括线粒体、错误折叠的蛋白质和脂质滴在内的受损细胞器来调节细胞器的周转和细胞能量平衡。自噬失调也会加重肝病。因此,自噬相关分子可以成为治疗肝病的潜在靶点。由于 ER 应激和自噬密切相关,了解参与这些过程的分子、基因簇和网络将有助于为酒精性和非酒精性肝病找到新的治疗方法。在这篇综述中,我们总结了分子发病机制方面的最新发现和观点。